EFFICACY AND SAFETY OF IXEKIZUMAB AT WEEK 52 IN BIOLOGIC NAIVE PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS (SPIRIT-P1)

被引：0

作者：

Lespessailles, Eric ^{[1
]}

Kirkham, Bruce ^{[2
,3
]}

Nebro, Antonio Fernandez ^{[4
]}

Blanco, Ricardo ^{[5
]}

Strehblow, Christoph ^{[6
]}

Inciarte-Mundo, Jose ^{[6
]}

Porsdal, Vibeke ^{[6
]}

Garcia, Miriam ^{[6
]}

Kurzawa, Monika ^{[6
]}

Sapin, Christophe ^{[6
]}

Geusens, Piet ^{[7
]}

Goupille, Philippe ^{[8
]}

Tahir, Hasan ^{[9
]}

机构：

[1] Univ Orleans, Hosp La Source, Rheumatol, Orleans, France

[2] Guys & St Thomas NHS Fdn Trust, Rheumatol, London, England

[3] Kings Coll London, London, England

[4] Univ Malaga, Hosp Reg Univ Malaga, Rheumatol, Malaga, Spain

[5] Univ Cantabria, Univ Hosp Valdecilla, Rheumatol, Santander, Spain

[6] Eli Lilly & Co, Lilly Int, Indianapolis, IN 46285 USA

[7] Univ Hasselt, Biomed Res Ctr, Diepenbeek, Belgium

[8] CHRU Tours, Serv Rhumatol, Tours, France

[9] Univ Hosp, Rheumatol, Whipps Cross Rd, London, England

来源：

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

181

引用

页数：2